Skip to main content
Equibles
SHC logo

SHC · Sotera Health Co · Earnings Call Transcripts & Audio

Track SHC — free

Use SHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.49 -0.11 (-0.59%) At close · Sep 30
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$5.23B
Shares
285.37M
Volume · Sep 30 2.03M Avg daily vol (3M) 2.59M

Sotera Health Co Earnings Call Transcripts

Quarterly earnings calls for Sotera Health Co (SHC), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲10% $248.70M $25.09M '22 Q3 22-11-02 ▲4.3% $251.59M −$408.00M '22 Q4 23-01-09 ▼6.8% $220.59M $2.84M '23 Q1 23-05-03 ▼4.3% $255.28M $23.51M '23 Q2 23-08-03 ▲5.8% $263.18M −$13.66M '23 Q3 23-11-01 ▲23.3% $310.24M $38.68M '23 Q4 24-02-27 ▲12.5% $248.18M $6.32M '24 Q1 24-05-02 ▲8.3% $276.59M $8.75M '24 Q2 24-08-05 ▲8.5% $285.47M $17.00M '24 Q3 24-11-05 ▼6.5% $290.20M $12.32M '24 Q4 25-02-27 ▲2.6% $254.52M −$13.26M '25 Q1 25-05-01 ▲6.4% $294.34M $7.96M '25 Q2 25-08-08 ▲9.1% $311.31M $48.40M '25 Q3 25-11-04 ▲4.6% $303.44M $34.85M '25 Q4 26-02-24 ▲10% $280.05M $26.59M '26 Q1 26-05-05 LATEST ▲9.2% $321.38M $53.64M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Sotera Health Co (SHC) Q2 2026 Earnings Call Transcript
Confident tone Segment performance and constant currency growth New CEO transition and leadership Ethylene oxide (EO) litigation
Revenue
$321.38M
▲ 9.2% YoY
Diluted EPS
$0.19
▲ 533.3% YoY
Gross margin
55.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Sotera Health Co (SHC) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Sotera Health Co (SHC) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Sotera Health Co (SHC) Q1 2026 Earnings Call Transcript
Confident tone Sterigenics segment performance Nelson Labs softness Nordion Cobalt-60 harvest timing benefit
Revenue
$280.05M
▲ 10% YoY
Diluted EPS
$0.09
Gross margin
52.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Sotera Health Co (SHC) Q4 2025 Earnings Call Transcript
Confident tone Sterigenics segment performance Long-range plan execution and 2026 outlook Nelson Labs
Revenue
$303.44M*
▲ 4.6% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Sotera Health Co (SHC) Q3 2025 Earnings Call Transcript
Confident tone Sterigenics performance 2025 guidance Nelson Labs turnaround
Revenue
$311.31M
▲ 9.1% YoY
Diluted EPS
$0.17
▲ 183.3% YoY
Gross margin
57.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-08
Sotera Health Co (SHC) Q2 2025 Earnings Call Transcript
Confident tone Sterigenics growth and volume recovery Nelson Labs margin expansion End market normalization / destocking
Revenue
$294.34M
▲ 6.4% YoY
Diluted EPS
$0.03
▲ 0% YoY
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Sotera Health Co (SHC) Q1 2025 Earnings Call Transcript
Confident tone Segment performance and growth Sterigenics pricing 2025 guidance and outlook
Revenue
$254.52M
▲ 2.6% YoY
Diluted EPS
$-0.05
▼ 350% YoY
Gross margin
53.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Sotera Health Co (SHC) Q4 2024 Earnings Call Transcript
Positive tone Revenue and EBITDA growth Nordion / cobalt-60 harvest timing Tariff exposure and risk
Revenue
$290.20M*
▼ 6.5% YoY
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Sotera Health Co (SHC) Q3 2024 Earnings Call Transcript
Positive tone Sterigenics segment performance Continuous glucose monitors / integrated solutions Nelson Labs performance
Revenue
$285.47M
▲ 8.5% YoY
Diluted EPS
$0.06
Gross margin
55.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Sotera Health Co (SHC) Q2 2024 Earnings Call Transcript
Positive tone Nordion Segment Sterigenics Segment Nelson Labs Segment
Revenue
$276.59M
▲ 8.3% YoY
Diluted EPS
$0.03
▼ 62.5% YoY
Gross margin
55.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Sotera Health Co (SHC) Q1 2024 Earnings Call Transcript
Positive tone Financial Results Sterigenics Segment Ethylene Oxide Litigation
Revenue
$248.18M
▲ 12.5% YoY
Diluted EPS
$0.02
▲ 100% YoY
Gross margin
51.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Sotera Health Co (SHC) Q4 2023 Earnings Call Transcript
Positive tone Nordion / Cobalt-60 Liquidity and leverage Revenue and EBITDA growth
Revenue
$310.24M*
▲ 23.3% YoY
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Sotera Health Co (SHC) Q3 2023 Earnings Call Transcript
Revenue
$263.18M
▲ 5.8% YoY
Diluted EPS
$-0.05
▼ 155.6% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Sotera Health Co (SHC) Q2 2023 Earnings Call Transcript
Revenue
$255.28M
▼ 4.3% YoY
Diluted EPS
$0.08
▼ 27.3% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Sotera Health Co (SHC) Q1 2023 Earnings Call Transcript
Revenue
$220.59M
▼ 6.8% YoY
Diluted EPS
$0.01
▼ 90.9% YoY
Gross margin
50.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Sotera Health Co (SHC) Q4 2022 Earnings Call Transcript
Revenue
$251.59M*
▲ 4.3% YoY
Gross margin
56.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Sotera Health Co (SHC) Q3 2022 Earnings Call Transcript
Revenue
$248.70M
▲ 10% YoY
Diluted EPS
$0.09
▼ 10% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Sotera Health Co (SHC) Q2 2022 Earnings Call Transcript
Revenue
$266.64M
▲ 5.8% YoY
Diluted EPS
$0.11
▼ 26.7% YoY
Gross margin
56.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Sotera Health Co (SHC) Q1 2022 Earnings Call Transcript
Revenue
$236.75M
▲ 11.6% YoY
Diluted EPS
$0.11
▲ 175% YoY
Gross margin
54.4%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Sotera Health Co (SHC) Q4 2021 Earnings Call Transcript
Revenue
$241.25M*
▲ 11.3% YoY
Gross margin
55.5%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Sotera Health Co (SHC) Q3 2021 Earnings Call Transcript
Revenue
$226.16M
▲ 13.1% YoY
Diluted EPS
$0.10
Gross margin
55.5%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Sotera Health Co (SHC) Q2 2021 Earnings Call Transcript
Revenue
$251.92M
▲ 18.2% YoY
Diluted EPS
$0.15
▲ 400% YoY
Gross margin
57.1%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Sotera Health Co (SHC) Q1 2021 Earnings Call Transcript
Revenue
$212.15M
▲ 12.7% YoY
Diluted EPS
$0.04
Gross margin
54.4%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-11
Sotera Health Co (SHC) Q4 2020 Earnings Call
Revenue
$216.84M*
Gross margin
55.6%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–25 of 25 earnings calls
Key facts CIK 1822479 CUSIP 83601L102 13F (30d) 10 filings 10 filers Visit website Investor relations